Chartwell Investment Partners »

Aeglea Biotherapeutics shares owned by Chartwell Investment Partners

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Chartwell Investment Partners from 13F filings

Historical chart of Chartwell Investment Partners investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Chartwell Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Chartwell Investment Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $259k 6.8k 37.96